However, patients with CRC often miss an optimal therapeutic window, because CRC is not detected due to lack of obvious signs and/or insufficient sensitivity of OBT or other biomarkers like carcinoembryonic antigen.42 Here, CEACAM5 is linked to colorectal carcinoma.